NCT06736769View on ClinicalTrials.gov

Ketamine Effects on Learning In Eating Disorders

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 5, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Anorexia NervosaAtypical Anorexia Nervosa
Interventions
DRUG

Ketamine infusion

Ketamine will be delivered intravenously at 0.5 mg/kg over 40 minutes.

Trial Locations (1)

94158

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

Amanda Downey, MD

OTHER